MedinCell S.A. (EPA:MEDCL)
16.79
+0.20 (1.21%)
Jun 27, 2025, 5:35 PM CET
MedinCell Balance Sheet
Financials in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | - | 19.46 | 6.47 | 24.62 | 47.1 | Upgrade
|
Short-Term Investments | - | - | 0 | 1.97 | 2.79 | Upgrade
|
Cash & Short-Term Investments | - | 19.46 | 6.47 | 26.59 | 49.88 | Upgrade
|
Cash Growth | - | 200.77% | -75.67% | -46.69% | 302.63% | Upgrade
|
Accounts Receivable | - | 2.25 | 2.09 | 0.8 | 0.88 | Upgrade
|
Other Receivables | - | 4.46 | 10.18 | 4.88 | 3.71 | Upgrade
|
Receivables | - | 6.71 | 12.27 | 5.68 | 4.59 | Upgrade
|
Prepaid Expenses | - | 0.97 | 0.74 | 1.14 | 0.87 | Upgrade
|
Other Current Assets | - | 0.12 | 0.08 | 0.67 | 0.99 | Upgrade
|
Total Current Assets | - | 27.26 | 19.57 | 34.07 | 56.33 | Upgrade
|
Property, Plant & Equipment | - | 5.43 | 6.37 | 7.03 | 3.85 | Upgrade
|
Long-Term Investments | - | 1.27 | 0.9 | 1.27 | 1.08 | Upgrade
|
Other Intangible Assets | - | 2.45 | 1.93 | 1.67 | 1.49 | Upgrade
|
Other Long-Term Assets | - | 0.54 | 0.57 | 0.26 | 0.86 | Upgrade
|
Total Assets | - | 36.95 | 29.34 | 44.3 | 63.61 | Upgrade
|
Accounts Payable | - | 1.85 | 4.18 | 2.98 | 2.96 | Upgrade
|
Accrued Expenses | - | 3.15 | 2.48 | 1.42 | 1.96 | Upgrade
|
Current Portion of Long-Term Debt | - | 5.52 | 42.81 | 27.76 | 3.18 | Upgrade
|
Current Portion of Leases | - | 0.64 | 0.64 | 0.58 | 0.39 | Upgrade
|
Current Unearned Revenue | - | 5.18 | 5.78 | 5.29 | 4.85 | Upgrade
|
Other Current Liabilities | - | 0.13 | 1.13 | 0.21 | 0.27 | Upgrade
|
Total Current Liabilities | - | 16.47 | 57.03 | 38.24 | 13.6 | Upgrade
|
Long-Term Debt | - | 56.29 | 11.71 | 16.25 | 39.07 | Upgrade
|
Long-Term Leases | - | 2.26 | 2.54 | 2.9 | 0.71 | Upgrade
|
Long-Term Unearned Revenue | - | - | - | - | 0.84 | Upgrade
|
Other Long-Term Liabilities | - | 2.4 | 0 | 0.02 | 0.02 | Upgrade
|
Total Liabilities | - | 77.77 | 71.63 | 57.67 | 54.48 | Upgrade
|
Common Stock | - | 0.29 | 0.25 | 0.25 | 0.25 | Upgrade
|
Additional Paid-In Capital | - | 31.01 | 7.42 | 6.91 | 75.15 | Upgrade
|
Retained Earnings | - | -25.04 | -32.01 | -24.81 | -18.99 | Upgrade
|
Comprehensive Income & Other | - | -47.09 | -17.95 | 4.27 | -47.28 | Upgrade
|
Total Common Equity | - | -40.82 | -42.29 | -13.37 | 9.13 | Upgrade
|
Shareholders' Equity | - | -40.82 | -42.29 | -13.37 | 9.13 | Upgrade
|
Total Liabilities & Equity | - | 36.95 | 29.34 | 44.3 | 63.61 | Upgrade
|
Total Debt | - | 64.71 | 57.71 | 47.49 | 43.35 | Upgrade
|
Net Cash (Debt) | - | -45.25 | -51.24 | -20.9 | 6.54 | Upgrade
|
Net Cash Per Share | - | -1.59 | -2.03 | -0.84 | 0.30 | Upgrade
|
Filing Date Shares Outstanding | - | 29.09 | 28.71 | 25.11 | 24.68 | Upgrade
|
Total Common Shares Outstanding | - | 29.07 | 25.28 | 25.11 | 24.68 | Upgrade
|
Working Capital | - | 10.79 | -37.46 | -4.17 | 42.73 | Upgrade
|
Book Value Per Share | - | -1.40 | -1.67 | -0.53 | 0.37 | Upgrade
|
Tangible Book Value | - | -43.27 | -44.22 | -15.04 | 7.64 | Upgrade
|
Tangible Book Value Per Share | - | -1.49 | -1.75 | -0.60 | 0.31 | Upgrade
|
Machinery | - | 7.64 | 7.36 | 7.14 | 5.69 | Upgrade
|
Construction In Progress | - | 0.04 | 0.26 | 0.13 | 0.05 | Upgrade
|
Updated Dec 10, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.